Novelix Pharmaceuticals (BOM:536565) E10: ₹-0.77 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:536565 Novelix Pharmaceuticals Ltd BOM:536565
50 GF Score
Price ₹80.90
! 7 Warning Signs
View Full Analysis

What is Novelix Pharmaceuticals E10?

Novelix Pharmaceuticals BOM:536565 +0.65% 50 E10 is ₹-0.77 as of Jun. 2026. GuruFocus rates BOM:536565 with a GF Score™ of 50/100. The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Novelix Pharmaceuticals's adjusted earnings per share data for the three months ended in Jun. 2026 was ₹0.490. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹-0.77 for the trailing ten years ended in Jun. 2026.

During the past 3 years, the average E10 Growth Rate was 3.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Novelix Pharmaceuticals was 3.90% per year. The lowest was -6.00% per year. And the median was -1.05% per year.

As of today (2026-08-26), Novelix Pharmaceuticals's current stock price is ₹80.90. Novelix Pharmaceuticals's E10 for the quarter that ended in Jun. 2026 was ₹-0.77. Novelix Pharmaceuticals's Shiller PE Ratio of today is .


Novelix Pharmaceuticals  (BOM:536565) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Novelix Pharmaceuticals E10 Related Terms


Novelix Pharmaceuticals E10 Historical Data

* Premium members only.

The historical data trend for Novelix Pharmaceuticals's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novelix Pharmaceuticals E10 Chart

Novelix Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.73 -0.89 -1.04 -0.87 -0.79

Novelix Pharmaceuticals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.91 -0.91 -0.80 -0.79 -0.77

BOM:536565 vs MCK, COR, CAH: E10 Comparison

For the Medical Distribution subindustry, Novelix Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novelix Pharmaceuticals Shiller PE Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Novelix Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Novelix Pharmaceuticals's Shiller PE Ratio falls into.


BOM:536565
50GF Score
Novelix Pharmaceuticals Ltd BOM:536565
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Novelix Pharmaceuticals E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Novelix Pharmaceuticals's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.49/167.3573*167.3573
=0.490

Current CPI (Jun. 2026) = 167.3573.

Novelix Pharmaceuticals Quarterly Data

per share eps CPI Adj_EPS
201512 0.080 102.901 0.130
201603 -0.180 102.518 -0.294
201606 -0.050 105.961 -0.079
201609 0.120 105.961 0.190
201612 0.130 105.196 0.207
201703 -0.220 105.196 -0.350
201803 -0.300 109.786 -0.457
201806 -0.160 111.317 -0.241
201809 -0.006 115.142 -0.009
201812 -0.150 115.142 -0.218
201903 0.110 118.202 0.156
201906 -0.030 120.880 -0.042
201909 -0.210 123.175 -0.285
201912 -0.133 126.235 -0.176
202003 0.039 124.705 0.052
202006 -0.110 127.000 -0.145
202009 -0.210 130.118 -0.270
202012 -0.260 130.889 -0.332
202103 -4.050 131.771 -5.144
202106 -0.092 134.084 -0.115
202109 0.390 135.847 0.480
202112 -0.020 138.161 -0.024
202203 -2.010 138.822 -2.423
202206 -0.070 142.347 -0.082
202209 -0.100 144.661 -0.116
202212 0.080 145.763 0.092
202303 0.020 146.865 0.023
202306 -0.210 150.280 -0.234
202309 -0.210 151.492 -0.232
202312 -0.040 152.924 -0.044
202403 0.341 153.035 0.373
202406 -0.430 155.789 -0.462
202409 0.160 157.882 0.170
202412 0.150 158.323 0.159
202503 0.180 157.552 0.191
202506 0.090 159.755 0.094
202509 0.370 162.289 0.382
202512 0.580 163.281 0.594
202603 0.320 164.272 0.326
202606 0.490 167.357 0.490

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹-0.77 mean?
Novelix Pharmaceuticals (BOM:536565) has a E10 of ₹-0.77 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Novelix Pharmaceuticals and its competitors.
Is Novelix Pharmaceuticals' E10 too high?
Novelix Pharmaceuticals' current E10 is ₹-0.77. Overall, Novelix Pharmaceuticals has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does Novelix Pharmaceuticals' E10 compare to MCK and COR?
Novelix Pharmaceuticals' E10 of ₹-0.77 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Distribution company?
A good E10 depends on the Medical Distribution industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Novelix Pharmaceuticals and its competitors. Novelix Pharmaceuticals's current E10 is ₹-0.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novelix Pharmaceuticals stock overvalued right now?
Novelix Pharmaceuticals (BOM:536565) has a current E10 of ₹-0.77. The current E10 is ₹-0.77. Novelix Pharmaceuticals' overall GF Score™ is 50/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Novelix Pharmaceuticals (BOM:536565), the current E10 is ₹-0.77 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Novelix Pharmaceuticals Business Description

Address Lingapur LA Builders, Amrutha Estates, 6th floor, House no. 3-6-237/610, Himayath nagar, Hyderabad, TG, IND, 500029
Novelix Pharmaceuticals Ltd is into the business of Trading of Pharmaceuticals and related products and is into the business of trading of shares and securities. The company generates majaority of its revenue from the Pharmaceuticals business.
50GF Score

Get the complete analysis for BOM:536565

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹80.90
Price